As shown in Fig. 7E, Prrx1 expression was positively correlated with SOX2 positive rate in glioma tissues, with 76.1% and 37% in Prrx1-high and Prrx1-low groups, respectively. This evidence concerns the gene PRRX1 and central nervous system cancer.